Sarfraz M - Search Results

1

Molecular modeling of pyrrolo-pyrimidine based analogs as potential FGFR1 inhibitors: a scientific approach for therapeutic drugs.

Raza A, Chohan TA, Sarfraz M, Chohan TA, Imran Sajid M, Tiwari RK, Ansari SA, Alkahtani HM, Yasmeen Ansari S, Khurshid U, Saleem H. Raza A, et al. Among authors: sarfraz m. J Biomol Struct Dyn. 2023;41(23):14358-14371. doi: 10.1080/07391102.2023.2187638. Epub 2023 Mar 10. J Biomol Struct Dyn. 2023. PMID: 36898855

2

Evaluation of anticancer potential of tetracene-5,12-dione (A01) and pyrimidine-2,4-dione (A02) via caspase 3 and lactate dehydrogenase cytotoxicity investigations.

Aziz M, Sarfraz M, Khurrum Ibrahim M, Ejaz SA, Zehra T, Ogaly HA, Arafat M, Al-Zahrani FAM, Li C. Aziz M, et al. Among authors: sarfraz m. PLoS One. 2023 Dec 21;18(12):e0292455. doi: 10.1371/journal.pone.0292455. eCollection 2023. PLoS One. 2023. PMID: 38127898 Free PMC article.

3

Beyond traditional medications: exploring novel and potential inhibitors of trypanothione reductase (LmTr) of Leishmania parasites.

Sarfraz M, Bakht MA, Alshammari MS, Alrofaidi M, Alzahrani AR, Eltaib L, Asdaq SMB, Aba Alkhayl FF, Abida, Mohd Imran. Sarfraz M, et al. J Biomol Struct Dyn. 2024 Jan 4:1-14. doi: 10.1080/07391102.2023.2300062. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38213287

4

Repurposing of Strychnine as the Potential Inhibitors of Aldo-keto Reductase Family 1 Members B1 and B10: Computational Modeling and Pharmacokinetic Analysis.

Sarfraz M, Aziz M, Afzal S, Channar PA, Alsfouk BA, Kandhro GA, Hassan S, Sultan A, Hamad A, Arafat M, Qaiser MN, Ahmed A, Siddique F, Ejaz SA. Sarfraz M, et al. Protein J. 2024 Apr;43(2):207-224. doi: 10.1007/s10930-023-10163-z. Epub 2023 Nov 8. Protein J. 2024. PMID: 37940790

5

An Integrated Computational Approaches for Designing of Potential Piperidine based Inhibitors of Alzheimer Disease by Targeting Cholinesterase and Monoamine Oxidases Isoenzymes.

Sarfraz M, Ibrahim MK, Ejaz SA, Attaullah HM, Aziz M, Arafat M, Shamim T, Elhadi M, Ruby T, Mahmood HK. Sarfraz M, et al. Appl Biochem Biotechnol. 2024 Jan 2. doi: 10.1007/s12010-023-04815-0. Online ahead of print. Appl Biochem Biotechnol. 2024. PMID: 38165591

6

Fabrication and Evaluation of Anticancer Potential of Eugenol Incorporated Chitosan-Silver Nanocomposites: In Vitro, In Vivo, and In Silico Studies.

Shah HS, Zaib S, Sarfraz M, Alhadhrami A, Ibrahim MM, Mushtaq A, Usman F, Ishtiaq M, Sajjad M, Asjad HMM, Gohar UF. Shah HS, et al. Among authors: sarfraz m. AAPS PharmSciTech. 2023 Aug 8;24(6):168. doi: 10.1208/s12249-023-02631-7. AAPS PharmSciTech. 2023. PMID: 37552378

7

Synthesis, characterization, pharmacological and computational evaluation of hyaluronic acid modified chebulinic acid encapsulated chitosan nanocomposite for cancer therapy.

Shah HS, Zaib S, Usman F, Sarfraz M, Faiz R, Rehman SA, Khan AA, Alanazi AM, Khan R, Nasrullah U, Nazir I. Shah HS, et al. Among authors: sarfraz m. Int J Biol Macromol. 2024 Apr;263(Pt 1):130160. doi: 10.1016/j.ijbiomac.2024.130160. Epub 2024 Feb 16. Int J Biol Macromol. 2024. PMID: 38367777

8

Formulation and characterization of thiolated chitosan/polyvinyl acetate based microneedle patch for transdermal delivery of dydrogesterone.

Khalid A, Shoaib Sarwar H, Sarfraz M, Farhan Sohail M, Jalil A, Bin Jardan YA, Arshad R, Tahir I, Ahmad Z. Khalid A, et al. Among authors: sarfraz m. Saudi Pharm J. 2023 May;31(5):669-677. doi: 10.1016/j.jsps.2023.03.007. Epub 2023 Mar 15. Saudi Pharm J. 2023. PMID: 37181138 Free PMC article.

9

Fabrication and evaluation of anticancer potential of diosgenin incorporated chitosan-silver nanoparticles; in vitro, in silico and in vivo studies.

Zaib S, Shah HS, Khan I, Jawad Z, Sarfraz M, Riaz H, Asjad HMM, Ishtiaq M, Ogaly HA, Othman G, Ahmed DAEM. Zaib S, et al. Among authors: sarfraz m. Int J Biol Macromol. 2024 Jan;254(Pt 3):127975. doi: 10.1016/j.ijbiomac.2023.127975. Epub 2023 Nov 8. Int J Biol Macromol. 2024. PMID: 37944715

10

Comparative analysis of phyto-fabricated chitosan, copper oxide, and chitosan-based CuO nanoparticles: antibacterial potential against Acinetobacter baumannii isolates and anticancer activity against HepG2 cell lines.

Sarfraz MH, Zubair M, Aslam B, Ashraf A, Siddique MH, Hayat S, Cruz JN, Muzammil S, Khurshid M, Sarfraz MF, Hashem A, Dawoud TM, Avila-Quezada GD, Abd Allah EF. Sarfraz MH, et al. Among authors: sarfraz mf. Front Microbiol. 2023 May 31;14:1188743. doi: 10.3389/fmicb.2023.1188743. eCollection 2023. Front Microbiol. 2023. PMID: 37323910 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page